脑白质高信号与自发性脑出血

doi:10.3969/j.issn.1004-583X.2021.06.017

摘要/Abstract

摘要：

自发性脑出血(sICH)具有很高的病死率和致残率,寻找可靠的风险标记物对于sICH的预防和预后改善极为重要。脑白质高信号(WMH)是脑小血管病的典型影像学标志之一,研究发现,WMH不仅与高血压、脑淀粉样血管病、脑微出血等引起的sICH发生风险增加及预后不良密切相关,其严重程度还与急性缺血性卒中静脉溶栓及血管内治疗后继发颅内出血相关。WMH患者长期使用抗凝药物也会增加脑出血的风险。WMH的检测有助于预测sICH的发生风险及预后,对预先存在的WMH进行积极干预可能成为脑出血患者预防和预后策略的新靶点。

关键词: 脑出血, 血肿, 脑白质疏松症, 预后

中图分类号:

R743.34

史晓英, 何洪真, 郭星, 吕佩源. 脑白质高信号与自发性脑出血[J]. 临床荟萃, 2021, 36(6): 562-565.

导出引用管理器 EndNote|Ris|BibTeX

链接本文: https://huicui.hebmu.edu.cn/CN/10.3969/j.issn.1004-583X.2021.06.017

https://huicui.hebmu.edu.cn/CN/Y2021/V36/I6/562

参考文献 32

[1]	Kongbunkiat K, Wilson D, Kasemsap N, et al. Leukoaraiosis, intracerebral hemorrhage, and functional outcome after acute stroke thrombolysis[J]. Neurology, 2017, 88(7):638-645. doi: 10.1212/WNL.0000000000003605 pmid: 28130468
[2]	Joutel A, Chabriat H. Pathogenesis of white matter changes in cerebral small vessel diseases: beyond vessel-intrinsic mechanisms[J]. Clin Sci, 2017, 131(8):635-651. doi: 10.1042/CS20160380 URL
[3]	中华医学会神经病学分会, 中华医学会神经病学分会脑血管病学组. 中国脑出血诊治指南(2019)[J]. 中华神经科杂志, 2019, 52(12):994-1005.
[4]	Hansen BM, Ullman N, Muschelli J, et al. Relationship of white matter lesions with intracerebral hemorrhage expansion and functional outcome: MISTIE II and CLEAR III[J]. Neurocritical Care, 2020, 33(2):516-524. doi: 10.1007/s12028-020-00916-4 pmid: 32026447
[5]	Ryu WS, Schellingerhout D, Hong KS, et al. White matter hyperintensity load on stroke recurrence and mortality at 1 year after ischemic stroke[J]. Neurology, 2019, 93(6):e578-e589. doi: 10.1212/WNL.0000000000007896 URL
[6]	Lee SH, Kim BJ, Ryu WS, et al. White matter lesions and poor outcome after intracerebral hemorrhage: A nationwide cohort study[J]. Neurology, 2010, 74(19):1502-1510. doi: 10.1212/WNL.0b013e3181dd425a pmid: 20458066
[7]	Morotti A, Shoamanesh A, Oliveira-Filho J, et al. White matter hyperintensities and blood pressure lowering in acute intracerebral hemorrhage: A secondary analysis of the ATACH-2 trial[J]. Neurocritical Care, 2019, 32(1):180-186. doi: 10.1007/s12028-019-00761-0 URL
[8]	Kaffashian S, Tzourio C, Zhu YC, et al. Differential effect of white-matter lesions and covert brain infarcts on the risk of ischemic stroke and intracerebral hemorrhage[J]. Stroke, 2016, 47(7):1923-1925. doi: 10.1161/STROKEAHA.116.012734 pmid: 27283199
[9]	Chen SJ, Tsai HH, Tsai LK, et al. Advances in cerebral amyloid angiopathy imaging[J]. Ther Adv Neurol Disord, 2019, 12:1756286419844113.
[10]	Gao Z, Wang W, Wang Z, et al. Cerebral microbleeds are associated with deep white matter hyperintensities, but only in hypertensive patients[J]. PLoS One, 2014, 9(3):e91637. doi: 10.1371/journal.pone.0091637 URL
[11]	De Leeuw FE, De Groot JC, Oudkerk M, et al. Hypertension and cerebral white matter lesions in a prospective cohort study[J]. Brain, 2002, 125(Pt 4):765-772. pmid: 11912110
[12]	Caprio FZ, Maas MB, Rosenberg NF, et al. Leukoaraiosis on magnetic resonance imaging correlates with worse outcomes after spontaneous intracerebral hemorrhage[J]. Stroke, 2013, 44(3):642-646. doi: 10.1161/STROKEAHA.112.676890 pmid: 23391853
[13]	Yu ZY, Zheng J, Guo R, et al. Prognostic significance of leukoaraiosis in intracerebral hemorrhage: A meta-analysis[J]. J Neurol Sci, 2019, 397:34-41. doi: 10.1016/j.jns.2018.12.022 URL
[14]	Charidimou A, Boulouis G, Haley K, et al. White matter hyperintensity patterns in cerebral amyloid angiopathy and hypertensive arteriopathy[J]. Neurology, 2016, 86(6):505-511. doi: 10.1212/WNL.0000000000002362 pmid: 26747886
[15]	Lioutas VA, Wu B, Norton C, Helenius J, et al. Cerebral small vessel disease burden and functional and radiographic outcomes in intracerebral hemorrhage[J]. J Neurol, 2018, 265(12):2803-2814. doi: 10.1007/s00415-018-9059-5 URL
[16]	Chen Y, Yan S, Xu M, et al. More extensive white matter hyperintensity is linked with higher risk of remote intracerebral hemorrhage after intravenous thrombolysis[J]. Eur J Neurol, 2018, 25(2):380-e15. doi: 10.1111/ene.13517 pmid: 29115734
[17]	Liu YY, Zhang M, Bao H, et al. The efficacy of intravenous thrombolysis in acute ischemic stroke patients with white matter hyperintensity[J]. Brain Behav, 2018, 8(12):e01149. doi: 10.1002/brb3.2018.8.issue-12 URL
[18]	Yang CM, Hung CL, Su HC, et al. Leukoaraiosis and risk of intracranial hemorrhage and outcome after stroke thrombolysis[J]. PLoS One, 2018, 13(5):e0196505.
[19]	Shi ZS, Loh Y, Liebeskind DS, et al. Leukoaraiosis predicts parenchymal hematoma after mechanical thrombectomy in acute ischemic stroke[J]. Stroke, 2012, 43(7):1806-1811. doi: 10.1161/STROKEAHA.111.649152 URL
[20]	Mistry EA, Mistry AM, Mehta T, et al. White matter disease and outcomes of mechanical thrombectomy for acute ischemic stroke[J]. AJNR Am J Neuroradiol, 2020, 41(4):639-644. doi: 10.3174/ajnr.A6478 URL
[21]	Atchaneeyasakul K, Leslie-Mazwi T, Donahue K, et al. White matter hyperintensity volume and outcome of mechanical thrombectomy with stentriever in acute ischemic stroke[J]. Stroke, 2017, 48(10):2892-2894. doi: 10.1161/STROKEAHA.117.018653 pmid: 28887393
[22]	Smith EE, Rosand J, Knudsen KA, et al. Leukoaraiosis is associated with warfarin-related hemorrhage following ischemic stroke[J]. Neurology, 2002, 59(2):193-197. pmid: 12136056
[23]	Martí-Fàbregas J, Medrano-Martorell S, Merino E, et al. MRI predicts intracranial hemorrhage in patients who receive long-term oral anticoagulation[J]. Neurology, 2019, 92(21):e2432-e2443. doi: 10.1212/WNL.0000000000007532 URL
[24]	Guo YT, Zi WJ, Wan Y, et al. Leukoaraiosis severity and outcomes after mechanical thrombectomy with stent-retriever devices in acute ischemic stroke[J]. J Neurointerv Surg, 2019, 11(2):137-140. doi: 10.1136/neurintsurg-2018-014018 URL
[25]	Demchuk AM, Khan F, Hill MD, et al. Importance of leukoaraiosis on ct for tissue plasminogen activator decision making: Evaluation of the NINDS rt-PA stroke study[J]. Cerebrovasc Dis, 2008, 26(2):120-125. doi: 10.1159/000139658 pmid: 18560214
[26]	Lou M, Al-Hazzani A, Goddeau Jr RP, et al. Relationship between white-matter hyperintensities and hematoma volume and growth in patients with intracerebral hemorrhage[J]. Stroke, 2010, 41(1):34-40. doi: 10.1161/STROKEAHA.109.564955 URL
[27]	Chen XM, Jin YX, Chen J, et al. Relationship between white matter hyperintensities and hematoma volume in patients with intracerebral hematoma[J]. Aging Dis, 2018, 9(6):999-1009. doi: 10.14336/AD.2018.0108 URL
[28]	Sykora M, Herweh C, Steiner C. The association between leukoaraiosis and poor outcome in intracerebral hemorrhage is not mediated by hematoma growth[J]. J Stroke Cerebrovasc Dis, 2017, 26(6):1328-1333. doi: S1052-3057(17)30048-4 pmid: 28237126
[29]	Vagal V, Venema SU, Behymer TP, et al. White matter lesion severity is associated with intraventricular hemorrhage in spontaneous intracerebral hemorrhage[J]. J Stroke Cerebrovasc Dis, 2020, 29(5):104661. doi: 10.1016/j.jstrokecerebrovasdis.2020.104661 URL
[30]	Kim BJ, Lee SH, Ryu WS, et al. Extents of white matter lesions and increased intraventricular extension of intracerebral hemorrhage[J]. Crit Care Med, 2013, 41(5):1325-1331. doi: 10.1097/CCM.0b013e31827c05e9 URL
[31]	Uniken Venema SM, Marini S, Brouwers HB, et al. Associations of radiographic cerebral small vessel disease with acute intracerebral hemorrhage volume, hematoma expansion, and intraventricular hemorrhage[J]. Neurocrit Care, 2020, 32(2):383-391. doi: 10.1007/s12028-019-00876-4 URL
[32]	中华医学会神经病学分会, 中华医学会神经病学分会脑血管病学组. 中国脑小血管病诊治共识[J]. 中华神经科杂志, 2015, 48(0):838-844.

脑白质高信号与自发性脑出血

RichHTML

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献 32

相关文章 15

编辑推荐

Metrics

本文评价

[1]	赵旭辉, 黄小敏, 达德转, 许焱, 崔晓东, 李红玲. 基于生物信息学筛选影响胃癌患者预后的糖酵解相关基因[J]. 临床荟萃, 2024, 39(1): 20-29.
[2]	刘丽丽, 袁宇婷, 赖耿良, 田川, 蓝翔, 叶中绿. 儿童急性淋巴细胞白血病第15天微小残留与预后的关系[J]. 临床荟萃, 2024, 39(1): 47-52.
[3]	崔兰丹, 杨春燕. 脓毒症患者甲状腺激素的变化特点及研究进展[J]. 临床荟萃, 2024, 39(1): 70-74.
[4]	王涛, 高玉伟, 王兴华, 胡秀红, 崔红蕊, 徐保振, 杨洪娟. 抗磷脂酶A2受体抗体与特发性膜性肾病的相关性[J]. 临床荟萃, 2023, 38(7): 606-612.
[5]	高秦宇, 包蓓艳, 金燕, 赵宇. IgA肾病合并抑郁状态患者的临床特征和预后影响因素分析[J]. 临床荟萃, 2023, 38(6): 510-515.
[6]	孙星星, 林海. 儿童重症肺炎的免疫功能变化及预后危险因素[J]. 临床荟萃, 2023, 38(6): 521-525.
[7]	贺翔渝, 潘燕, 张小林. 血清脂蛋白相关磷脂酶A2水平与急性缺血性脑卒中病情及预后的关系[J]. 临床荟萃, 2023, 38(4): 315-318.
[8]	杨金强, 张仁敏. 降钙素原与血小板比值评估发热伴血小板减少综合征预后的价值[J]. 临床荟萃, 2023, 38(4): 346-351.
[9]	张娜, 孙越, 董晗, 赵鹏, 杨昕, 祁源, 王玲玲. SPARC表达水平与非小细胞肺癌患者预后关系的meta分析[J]. 临床荟萃, 2023, 38(11): 972-978.
[10]	王会新, 赵芳晴, 张馨妍, 侯晓雯. 中国人尿酸水平与急性缺血性脑卒中患者预后关系的meta分析[J]. 临床荟萃, 2022, 37(9): 785-790.
[11]	邢婷婷, 高俊茶. Presepsin在急性胰腺炎中的研究进展[J]. 临床荟萃, 2022, 37(8): 764-768.
[12]	轩晓倩, 赵君慧, 杨小茜. 炎性指标在非小细胞肺癌患者预后中的临床意义[J]. 临床荟萃, 2022, 37(7): 663-667.
[13]	叶倩, 凌志, 刘申香, 路国涛, 殷旭东. 糖皮质激素对晚期肿瘤患者免疫疗效影响的Meta分析[J]. 临床荟萃, 2022, 37(7): 591-598.
[14]	周彬, 曾词正, 黄宇戈, 钟娩玲, 吴家园. pSOFA评分联合C-反应蛋白、降钙素原在脓毒症患儿预后评估中的作用[J]. 临床荟萃, 2022, 37(7): 616-622.
[15]	章敬水, 徐亚男, 王钧, 杨毅, 姜海兵, 唐龙, 王贤平, 邵名亮. 新发的不同类型心力衰竭合并心房颤动的临床特点和远期预后分析[J]. 临床荟萃, 2022, 37(6): 504-509.